The cost of diabetes in adults in Australia

Diabetes Research and Clinical Practice

Volumn 99, Issue 3, 2013, Pages 385-390

  Lee, Crystal Man Ying ^a   Colagiuri, Ruth ^a   Magliano, Dianna J ^b   Cameron, Adrian J ^c   Shaw, Jonathan ^b   Zimmet, Paul ^b   Colagiuri, Stephen ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

Author keywords

Adults; Australian; Diabetes; Direct health cost

Indexed keywords

ADULT; AGE; ARTICLE; AUSTRALIA; CHEMICAL ANALYSIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HEALTH CARE COST; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; QUESTIONNAIRE; SEX RATIO; VASCULAR DISEASE;

ADULT; AUSTRALIA; COST OF ILLNESS; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FINANCING, GOVERNMENT; GLUCOSE INTOLERANCE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED;

EID: 84876170352     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.12.002     Document Type: Article

References (21)

1. Whiting D.R., Guariguata L., Weil C., Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011, 94:311-321.
2. Zhang P., Zhang X., Brown J., Vistisen D., Sicree R., Shaw J., et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:293-301.
3. Magliano D.J., Shaw J.E., Shortreed S.M., Nusselder W.J., Liew D., Barr E.L., et al. Lifetime risk and projected population prevalence of diabetes. Diabetologia 2008, 51:2179-2186.
4. Mathers C, Penm R. Health system costs of cardiovascular diseases and diabetes in Australia 1993-94. AIHW cat. No. HWE 11. Canberra: Australian Institute of Health and Welfare (Health and Welfare Expenditure Series no. 5); 1999.
5. Colagiuri S., Colagiuri R., Conway B., Grainage D., Davey P. DiabCo$t Australia: assessing the burden of type 2 diabetes in Australia 2003, Diabetes Australia, Canberra.
6. Barr E.L., Magliano D.J., Zimmet P.Z., Polkinghorne K.R., Atkins R.C., Dunstan D.W., et al. The Australian Diabetes, Obesity and Lifestyle Study. Tracking the accelerating epidemic: its causes and outcomes 2006, International Diabetes Institute, Melbourne.
7. Magliano D.J., Barr E.L., Zimmet P.Z., Cameron A.J., Dunstan D.W., Colagiuri S., et al. Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2008, 31:267-272.
8. World Health Organization Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation 2006, World Health Organization, Geneva.
9. Olveira-Fuster G., Olvera-Marquez P., Carral-Sanlaureano F., Gonzalez-Romero S., Aquilar-Diosdado M., Soriquer-Escofet F. Excess hospitalizations, hospital days, and inpatient costs among people with diabetes in Andalusia, Spain. Diabetes Care 2004, 27:1904-1909.
10. Bruno G., Karaghiosoff L., Merletti F., Costa G., De Maria M., Panero F., et al. The impact of diabetes on prescription drug costs: the population-based Turin study. Diabetologia 2008, 51:795-801.
11. Davis W.A., Knuiman M.W., Hendrie D., Davis T.M.E. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study. Intern Med J 2006, 36:155-161.
12. Clarke P., Kelman C., Colagiuri S. Factors influencing the cost of hospital care for people with diabetes in Australia. J Diabetes Complications 2006, 20:349-355.
13. Koster I., von Ferber L., Ihle P., Schubert I., Hauner H. The cost burden of diabetes mellitus: the evidence from Germany - the CoDiM study. Diabetologia 2006, 49:1498-1504.
14. American Diabetes Association Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008, 31:596-615.
15. Davis W.A., Knuiman M.W., Hendrie D., Davis T.M.E. Determinants of diabetes-attributable non-blood glucose-lowering medication costs in type 2 diabetes. The Fremantle Diabetes Study. Diabetes Care 2005, 28:329-336.
16. Ali S., Stone M.A., Peters J.L., Davies M.J., Khunti K. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med 2006, 23:1165-1173.
17. Bosmans J.E., Adriaanse M.C. Outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting. BMC Health Serv Res 2012, 12:46.
18. Clarke P., Leal J., Kelman C., Smith M., Colagiuri S. Estimating the cost of complications of diabetes in Australia using administrative health-care data. Value Health 2008, 11:199-206.
19. Magliano D.J., Barr E.L., Zimmet P.Z., Cameron A.J., Dunstan D.W., Colagiuri S., et al. Glucose indices, health behaviors, and incidence of diabetes in Australia. The Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2008, 31:267-272.
20. Palmer A.J., Valentine W.J., Ray J.A. Cost-effectiveness studies of diabetes prevention in high-risk patients. Expert Rev Pharmacoecon Outcomes Res 2004, 4:393-402.
21. Gilmer T.P., Roze S., Valentine W.J., Emy-Albrecht K., Ray J.A., Cobden D., et al. Cost-effectiveness of diabetes case management for low-income populations. Health Serv Res 2007, 42:1943-1959.